Cargando…

Metabolic Traits in Cutaneous Melanoma

Tumor microenvironment is a network of complex cellular and molecular systems where cells will gain specific phenotypes and specific functions that would drive tumorigenesis. In skin cancers, tumor microenvironment is characterized by tumor infiltrating immune cells that sustain immune suppression,...

Descripción completa

Detalles Bibliográficos
Autor principal:	Neagu, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248353/ https://www.ncbi.nlm.nih.gov/pubmed/32509589 http://dx.doi.org/10.3389/fonc.2020.00851

Ejemplares similares

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming
por: Zuo, Sipeng, et al.
Publicado: (2022)

Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016)

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
por: Takabe, Piia, et al.
Publicado: (2022)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma
por: Dobre, Elena-Georgiana, et al.
Publicado: (2021)

Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling
por: Yu, Jie, et al.
Publicado: (2020)

The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness
por: Cabaço, Luís C., et al.
Publicado: (2022)

Association of JAK/STAT genetic variants with cutaneous melanoma
por: Gomez, Gabriela Vilas Bôas, et al.
Publicado: (2022)

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience
por: Crispo, Anna, et al.
Publicado: (2021)

Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma
por: Holder, Ashley M., et al.
Publicado: (2020)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
por: Scatena, Cristian, et al.
Publicado: (2021)

Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
por: Thornton, Jessica, et al.
Publicado: (2022)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations
por: Neagu, Monica, et al.
Publicado: (2013)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
por: Zhao, Xiaobei, et al.
Publicado: (2019)

Identification of Genes Related to Immune Infiltration in the Tumor Microenvironment of Cutaneous Melanoma
por: Qin, Rujia, et al.
Publicado: (2021)

The Role of the Vitamin D Receptor in the Pathogenesis, Prognosis, and Treatment of Cutaneous Melanoma
por: Becker, Alyssa L., et al.
Publicado: (2021)

Bioinformatic-based genetic characterizations of neural regulation in skin cutaneous melanoma
por: Wang, Fengdi, et al.
Publicado: (2023)

MACC1 and MET as markers associated with progression and metastasis in cutaneous melanoma
por: Zhou, Yan, et al.
Publicado: (2023)

Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis
por: Neagu, Monica, et al.
Publicado: (2015)

Recognition of Cutaneous Melanoma on Digitized Histopathological Slides via Artificial Intelligence Algorithm
por: De Logu, Francesco, et al.
Publicado: (2020)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021)

Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
por: Buja, Alessandra, et al.
Publicado: (2021)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
por: Nurzat, Yeltai, et al.
Publicado: (2023)

Inflammatory Cytokine Pattern Is Sex-Dependent in Mouse Cutaneous Melanoma Experimental Model
por: Surcel, Mihaela, et al.
Publicado: (2017)

To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?
por: Marciano, N J, et al.
Publicado: (2014)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma
por: Zhang, Fangyingnan, et al.
Publicado: (2022)

Characteristics, Prognosis, and Competing Risk Nomograms of Cutaneous Malignant Melanoma: Evidence for Pigmentary Disorders
por: Li, Zichao, et al.
Publicado: (2022)

The Great Mimicker: Cutaneous Metastatic Melanoma Presenting as a Non-resolving Pleural Effusion
por: Vajta Gomez, Jackeline P, et al.
Publicado: (2022)

Angiopoietin-2 expression and its relationship with lymphangiogenesis and clinicopathological characteristics in cutaneous malignant melanoma
por: Zheng, Wei, et al.
Publicado: (2023)

Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating
por: Georgescu, Simona Roxana, et al.
Publicado: (2022)

Linear Malignant Melanoma In Situ: Reports and Review of Cutaneous Malignancies Presenting as Linear Skin Cancer
por: Cohen, Philip R
Publicado: (2017)

A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma
por: Tong, Xiaoxia, et al.
Publicado: (2021)

ATG5 and ATG7 Expression Levels Are Reduced in Cutaneous Melanoma and Regulated by NRF1
por: Frangež, Živa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5v75i7n1fhk439078cap1gnrbr